B

Belite Bio
D

BLTE

80.260
USD
-2.20
(-2.67%)
مغلق
حجم التداول
2,201
الربح لكل سهم
-1
العائد الربحي
-
P/E
-73
حجم السوق
2,478,375,186
الأخبار

العنوان: Belite Bio

القطاع: Healthcare
الصناعة: Biotechnology
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.